# FDA 483 - INNOVATION LABS, INC. - July 05, 2022

Source: https://www.keypedia.com/records/483/innovation-labs-inc/2ffc0518-50a4-47e6-bcdd-bd55ef533689

> FDA 483 for INNOVATION LABS, INC. on July 05, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: INNOVATION LABS, INC.
- Inspection Date: 2022-07-05
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: Innovation Labs, Inc. in Mahwah, NJ, an OTC drug manufacturer, was cited for significant deficiencies during an FDA inspection from June 21 to July 5, 2022. Observations included a lack of written quality control procedures, inadequate production and process controls, unsanitary building conditions, and malfunctioning equipment. These issues indicate a general lack of control over manufacturing processes and quality assurance.

## Related Officers

- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Drug Investigator](https://www.keypedia.com/people/jessica-s-estriplet/b7152ec3-6e1b-45aa-840e-7147f357aea2)
- [Investigator](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)

Company: https://www.keypedia.com/companies/innovation-labs-inc/2b22d835-eb81-42c5-813d-d9116a968f2c

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248